1. Home
  2. DMRC vs EMBC Comparison

DMRC vs EMBC Comparison

Compare DMRC & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digimarc Corporation

DMRC

Digimarc Corporation

HOLD

Current Price

$9.48

Market Cap

170.6M

Sector

Technology

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

BUY

Current Price

$3.13

Market Cap

200.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
DMRC
EMBC
Founded
2008
1924
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.6M
200.5M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
DMRC
EMBC
Price
$9.48
$3.13
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$10.00
$18.50
AVG Volume (30 Days)
276.6K
2.1M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
18.58
20.90
EPS
N/A
0.67
Revenue
$25,213,000.00
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.64
Revenue Growth
15.69
N/A
52 Week Low
$4.07
$2.77
52 Week High
$17.47
$15.55

Technical Indicators

Market Signals
Indicator
DMRC
EMBC
Relative Strength Index (RSI) 38.41 27.72
Support Level $9.52 $3.02
Resistance Level $10.31 $3.48
Average True Range (ATR) 1.26 0.17
MACD -0.68 0.15
Stochastic Oscillator 3.78 17.31

Price Performance

Historical Comparison
DMRC
EMBC

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: